Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 7.

Eckert, C; Hagedorn, N; Sramkova, L; Mann, G; Panzer-Grümayer, R; Peters, C; Bourquin, J-P; Klingebiel, T; Borkhardt, A; Cario, G; Alten, J; Escherich, G; Astrahantseff, K; Seeger, K; Henze, G; von Stackelberg, A (2015). Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment. Leukemia, 29(8):1648-1655.

Snowden, J A; Saccardi, R; Allez, M; Ardizzone, S; Arnold, R; Cervera, R; Denton, C; Hawkey, C; Labopin, M; Mancardi, G; Martin, R; Moore, J J; Passweg, J; Peters, C; Rabusin, M; Rovira, M; van Laar, J M; Farge, D (2012). Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation, 47(6):770-790.

Strahm, B; Nöllke, P; Zecca, M; Korthof, E T; Bierings, M; Furlan, I; Sedlacek, P; Chybicka, A; Schmugge, M; Bordon, V; Peters, C; O'Marcaigh, A; de Heredia, C D; Bergstraesser, E; Moerloose, B D; van den Heuvel-Eibrink, M M; Starý, J; Trebo, M; Wojcik, D; Niemeyer, C M; Locatelli, F (2011). Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Leukemia, 25(3):455-462.

Booth, C; Gilmour, K C; Veys, P; Gennery, A R; Slatter, M A; Chapel, H; Heath, P T; Steward, C G; Smith, O; O'Meara, A; Kerrigan, H; Mahlaoui, N; Cavazzana-Calvo, M; Fischer, A; Moshous, D; Blanche, S; Pachlopnik Schmid, J; Latour, S; de Saint-Basile, G; Albert, M; Notheis, G; Rieber, N; Strahm, B; Ritterbusch, H; Lankester, A; Hartwig, N G; Meyts, I; Plebani, A; Soresina, A; Finocchi, A; Pignata, C; Cirillo, E; Bonanomi, S; Peters, C; Kalwak, K; Pasic, S; Sedlacek, P; Jazbec, J; Kanegane, H; Nichols, K E; Hanson, I C; Kapoor, N; Haddad, E; Cowan, M; Choo, S; Smart, J; Arkwright, P D; Gaspar, H B (2011). X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood, 117(1):53-62.

Zhu, Y; Peters, C; Hallier-Neelsen, M; Miller, D; Pagenstecher, A; Bertalanffy, H; Sure, U (2009). Phosphatase and tensin homolog in cerebral cavernous malformation: a potential role in pathological angiogenesis. Journal of Neurosurgery, 40(3):820-826.

Zhu, Y; Wloch, A; Wu, Q; Peters, C; Pagenstecher, A; Bertalanffy, H; Sure, U (2009). Involvement of PTEN Promoter Methylation in Cerebral Cavernous Malformations. Stroke, 40(3):820-826.

Harmann, D; Braschler, M; Hess, M; Kluck, M; Peters, C; Schuble, P; Sheridan, P (2000). CLIR Evaluation at TREC Cross-Language Information Retrieval and Evaluation. London, UK: Springer.

This list was generated on Sun Sep 24 10:05:45 2017 CEST.